Global Amlodipine Besylate Tablets Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.
LPI (LP Information)' newest research report, the “Amlodipine Besylate Tablets Industry Forecast” looks at past sales and reviews total world Amlodipine Besylate Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Amlodipine Besylate Tablets sales for 2023 through 2029. With Amlodipine Besylate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amlodipine Besylate Tablets industry.
This Insight Report provides a comprehensive analysis of the global Amlodipine Besylate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amlodipine Besylate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amlodipine Besylate Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amlodipine Besylate Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amlodipine Besylate Tablets.
The global Amlodipine Besylate Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amlodipine Besylate Tablets players cover China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amlodipine Besylate Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Amlodipine Besylate Tablets market?
What factors are driving Amlodipine Besylate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amlodipine Besylate Tablets market opportunities vary by end market size?
How does Amlodipine Besylate Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Amlodipine besylate is a dihydropyridine calcium channel antagonist, which can selectively inhibit cell membrane calcium ion channels, act on smooth muscle cells and cardiomyocytes, effectively regulate intracellular calcium levels, and enable normal physiological functions. Maintain, thereby dilate the coronary blood vessels and the blood vessels of the whole body, and lower blood pressure. Clinically, it is generally used to treat hypertensive coronary heart disease and essential hypertension. Amlodipine can be used alone or in combination with other antihypertensive drugs, chronic stable angina and variant angina.
LPI (LP Information)' newest research report, the “Amlodipine Besylate Tablets Industry Forecast” looks at past sales and reviews total world Amlodipine Besylate Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Amlodipine Besylate Tablets sales for 2023 through 2029. With Amlodipine Besylate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amlodipine Besylate Tablets industry.
This Insight Report provides a comprehensive analysis of the global Amlodipine Besylate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amlodipine Besylate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Amlodipine Besylate Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amlodipine Besylate Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amlodipine Besylate Tablets.
The global Amlodipine Besylate Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Amlodipine Besylate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Amlodipine Besylate Tablets players cover China Resources Double-Crane Pharmaceutical, Pfizer, North China Pharmaceutical, AstraZeneca, Sanofi, Roche, Bristol-Myers Squibb, Yangtze River Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Amlodipine Besylate Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 5 Milligrams
- 10 Milligrams
- Hospital
- Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- China Resources Double-Crane Pharmaceutical
- Pfizer
- North China Pharmaceutical
- AstraZeneca
- Sanofi
- Roche
- Bristol-Myers Squibb
- Yangtze River Pharmaceutical
- Shanghai Shyndec Pharmaceutical
- Jingfeng Pharmaceutical
What is the 10-year outlook for the global Amlodipine Besylate Tablets market?
What factors are driving Amlodipine Besylate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amlodipine Besylate Tablets market opportunities vary by end market size?
How does Amlodipine Besylate Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amlodipine Besylate Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amlodipine Besylate Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amlodipine Besylate Tablets by Country/Region, 2018, 2022 & 2029
2.2 Amlodipine Besylate Tablets Segment by Type
2.2.1 5 Milligrams
2.2.2 10 Milligrams
2.3 Amlodipine Besylate Tablets Sales by Type
2.3.1 Global Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amlodipine Besylate Tablets Sale Price by Type (2018-2023)
2.4 Amlodipine Besylate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amlodipine Besylate Tablets Sales by Application
2.5.1 Global Amlodipine Besylate Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amlodipine Besylate Tablets Sale Price by Application (2018-2023)
3 GLOBAL AMLODIPINE BESYLATE TABLETS BY COMPANY
3.1 Global Amlodipine Besylate Tablets Breakdown Data by Company
3.1.1 Global Amlodipine Besylate Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Amlodipine Besylate Tablets Sales Market Share by Company (2018-2023)
3.2 Global Amlodipine Besylate Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Amlodipine Besylate Tablets Revenue by Company (2018-2023)
3.2.2 Global Amlodipine Besylate Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Amlodipine Besylate Tablets Sale Price by Company
3.4 Key Manufacturers Amlodipine Besylate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amlodipine Besylate Tablets Product Location Distribution
3.4.2 Players Amlodipine Besylate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMLODIPINE BESYLATE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Amlodipine Besylate Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Amlodipine Besylate Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amlodipine Besylate Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amlodipine Besylate Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Amlodipine Besylate Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amlodipine Besylate Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amlodipine Besylate Tablets Sales Growth
4.4 APAC Amlodipine Besylate Tablets Sales Growth
4.5 Europe Amlodipine Besylate Tablets Sales Growth
4.6 Middle East & Africa Amlodipine Besylate Tablets Sales Growth
5 AMERICAS
5.1 Americas Amlodipine Besylate Tablets Sales by Country
5.1.1 Americas Amlodipine Besylate Tablets Sales by Country (2018-2023)
5.1.2 Americas Amlodipine Besylate Tablets Revenue by Country (2018-2023)
5.2 Americas Amlodipine Besylate Tablets Sales by Type
5.3 Americas Amlodipine Besylate Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amlodipine Besylate Tablets Sales by Region
6.1.1 APAC Amlodipine Besylate Tablets Sales by Region (2018-2023)
6.1.2 APAC Amlodipine Besylate Tablets Revenue by Region (2018-2023)
6.2 APAC Amlodipine Besylate Tablets Sales by Type
6.3 APAC Amlodipine Besylate Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amlodipine Besylate Tablets by Country
7.1.1 Europe Amlodipine Besylate Tablets Sales by Country (2018-2023)
7.1.2 Europe Amlodipine Besylate Tablets Revenue by Country (2018-2023)
7.2 Europe Amlodipine Besylate Tablets Sales by Type
7.3 Europe Amlodipine Besylate Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amlodipine Besylate Tablets by Country
8.1.1 Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Amlodipine Besylate Tablets Sales by Type
8.3 Middle East & Africa Amlodipine Besylate Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amlodipine Besylate Tablets
10.3 Manufacturing Process Analysis of Amlodipine Besylate Tablets
10.4 Industry Chain Structure of Amlodipine Besylate Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amlodipine Besylate Tablets Distributors
11.3 Amlodipine Besylate Tablets Customer
12 WORLD FORECAST REVIEW FOR AMLODIPINE BESYLATE TABLETS BY GEOGRAPHIC REGION
12.1 Global Amlodipine Besylate Tablets Market Size Forecast by Region
12.1.1 Global Amlodipine Besylate Tablets Forecast by Region (2024-2029)
12.1.2 Global Amlodipine Besylate Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amlodipine Besylate Tablets Forecast by Type
12.7 Global Amlodipine Besylate Tablets Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 China Resources Double-Crane Pharmaceutical
13.1.1 China Resources Double-Crane Pharmaceutical Company Information
13.1.2 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 China Resources Double-Crane Pharmaceutical Main Business Overview
13.1.5 China Resources Double-Crane Pharmaceutical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Amlodipine Besylate Tablets Product Portfolios and Specifications
13.2.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Amlodipine Besylate Tablets Product Portfolios and Specifications
13.4.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Amlodipine Besylate Tablets Product Portfolios and Specifications
13.5.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Amlodipine Besylate Tablets Product Portfolios and Specifications
13.6.3 Roche Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Yangtze River Pharmaceutical
13.8.1 Yangtze River Pharmaceutical Company Information
13.8.2 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical Main Business Overview
13.8.5 Yangtze River Pharmaceutical Latest Developments
13.9 Shanghai Shyndec Pharmaceutical
13.9.1 Shanghai Shyndec Pharmaceutical Company Information
13.9.2 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.10 Jingfeng Pharmaceutical
13.10.1 Jingfeng Pharmaceutical Company Information
13.10.2 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jingfeng Pharmaceutical Main Business Overview
13.10.5 Jingfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amlodipine Besylate Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Amlodipine Besylate Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Amlodipine Besylate Tablets by Country/Region, 2018, 2022 & 2029
2.2 Amlodipine Besylate Tablets Segment by Type
2.2.1 5 Milligrams
2.2.2 10 Milligrams
2.3 Amlodipine Besylate Tablets Sales by Type
2.3.1 Global Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Amlodipine Besylate Tablets Sale Price by Type (2018-2023)
2.4 Amlodipine Besylate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Amlodipine Besylate Tablets Sales by Application
2.5.1 Global Amlodipine Besylate Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Amlodipine Besylate Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Amlodipine Besylate Tablets Sale Price by Application (2018-2023)
3 GLOBAL AMLODIPINE BESYLATE TABLETS BY COMPANY
3.1 Global Amlodipine Besylate Tablets Breakdown Data by Company
3.1.1 Global Amlodipine Besylate Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Amlodipine Besylate Tablets Sales Market Share by Company (2018-2023)
3.2 Global Amlodipine Besylate Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Amlodipine Besylate Tablets Revenue by Company (2018-2023)
3.2.2 Global Amlodipine Besylate Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Amlodipine Besylate Tablets Sale Price by Company
3.4 Key Manufacturers Amlodipine Besylate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amlodipine Besylate Tablets Product Location Distribution
3.4.2 Players Amlodipine Besylate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR AMLODIPINE BESYLATE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Amlodipine Besylate Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Amlodipine Besylate Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Amlodipine Besylate Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Amlodipine Besylate Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Amlodipine Besylate Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Amlodipine Besylate Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Amlodipine Besylate Tablets Sales Growth
4.4 APAC Amlodipine Besylate Tablets Sales Growth
4.5 Europe Amlodipine Besylate Tablets Sales Growth
4.6 Middle East & Africa Amlodipine Besylate Tablets Sales Growth
5 AMERICAS
5.1 Americas Amlodipine Besylate Tablets Sales by Country
5.1.1 Americas Amlodipine Besylate Tablets Sales by Country (2018-2023)
5.1.2 Americas Amlodipine Besylate Tablets Revenue by Country (2018-2023)
5.2 Americas Amlodipine Besylate Tablets Sales by Type
5.3 Americas Amlodipine Besylate Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amlodipine Besylate Tablets Sales by Region
6.1.1 APAC Amlodipine Besylate Tablets Sales by Region (2018-2023)
6.1.2 APAC Amlodipine Besylate Tablets Revenue by Region (2018-2023)
6.2 APAC Amlodipine Besylate Tablets Sales by Type
6.3 APAC Amlodipine Besylate Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amlodipine Besylate Tablets by Country
7.1.1 Europe Amlodipine Besylate Tablets Sales by Country (2018-2023)
7.1.2 Europe Amlodipine Besylate Tablets Revenue by Country (2018-2023)
7.2 Europe Amlodipine Besylate Tablets Sales by Type
7.3 Europe Amlodipine Besylate Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amlodipine Besylate Tablets by Country
8.1.1 Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Amlodipine Besylate Tablets Sales by Type
8.3 Middle East & Africa Amlodipine Besylate Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amlodipine Besylate Tablets
10.3 Manufacturing Process Analysis of Amlodipine Besylate Tablets
10.4 Industry Chain Structure of Amlodipine Besylate Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amlodipine Besylate Tablets Distributors
11.3 Amlodipine Besylate Tablets Customer
12 WORLD FORECAST REVIEW FOR AMLODIPINE BESYLATE TABLETS BY GEOGRAPHIC REGION
12.1 Global Amlodipine Besylate Tablets Market Size Forecast by Region
12.1.1 Global Amlodipine Besylate Tablets Forecast by Region (2024-2029)
12.1.2 Global Amlodipine Besylate Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Amlodipine Besylate Tablets Forecast by Type
12.7 Global Amlodipine Besylate Tablets Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 China Resources Double-Crane Pharmaceutical
13.1.1 China Resources Double-Crane Pharmaceutical Company Information
13.1.2 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.1.3 China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 China Resources Double-Crane Pharmaceutical Main Business Overview
13.1.5 China Resources Double-Crane Pharmaceutical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Amlodipine Besylate Tablets Product Portfolios and Specifications
13.2.3 Pfizer Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Amlodipine Besylate Tablets Product Portfolios and Specifications
13.4.3 AstraZeneca Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Amlodipine Besylate Tablets Product Portfolios and Specifications
13.5.3 Sanofi Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Amlodipine Besylate Tablets Product Portfolios and Specifications
13.6.3 Roche Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Yangtze River Pharmaceutical
13.8.1 Yangtze River Pharmaceutical Company Information
13.8.2 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical Main Business Overview
13.8.5 Yangtze River Pharmaceutical Latest Developments
13.9 Shanghai Shyndec Pharmaceutical
13.9.1 Shanghai Shyndec Pharmaceutical Company Information
13.9.2 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.9.3 Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.10 Jingfeng Pharmaceutical
13.10.1 Jingfeng Pharmaceutical Company Information
13.10.2 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
13.10.3 Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jingfeng Pharmaceutical Main Business Overview
13.10.5 Jingfeng Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amlodipine Besylate Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amlodipine Besylate Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5 Milligrams
Table 4. Major Players of 10 Milligrams
Table 5. Global Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 6. Global Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Amlodipine Besylate Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Amlodipine Besylate Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 11. Global Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Amlodipine Besylate Tablets Revenue by Application (2018-2023)
Table 13. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Amlodipine Besylate Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Amlodipine Besylate Tablets Sales by Company (2018-2023) & (K Units)
Table 16. Global Amlodipine Besylate Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Amlodipine Besylate Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Amlodipine Besylate Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Amlodipine Besylate Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Amlodipine Besylate Tablets Producing Area Distribution and Sales Area
Table 21. Players Amlodipine Besylate Tablets Products Offered
Table 22. Amlodipine Besylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amlodipine Besylate Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Amlodipine Besylate Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Amlodipine Besylate Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Amlodipine Besylate Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Amlodipine Besylate Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Amlodipine Besylate Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Amlodipine Besylate Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Amlodipine Besylate Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 34. Americas Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 38. Americas Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 39. APAC Amlodipine Besylate Tablets Sales by Region (2018-2023) & (K Units)
Table 40. APAC Amlodipine Besylate Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Amlodipine Besylate Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Amlodipine Besylate Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 44. APAC Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 45. Europe Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 46. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 50. Europe Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Amlodipine Besylate Tablets
Table 58. Key Market Challenges & Risks of Amlodipine Besylate Tablets
Table 59. Key Industry Trends of Amlodipine Besylate Tablets
Table 60. Amlodipine Besylate Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Amlodipine Besylate Tablets Distributors List
Table 63. Amlodipine Besylate Tablets Customer List
Table 64. Global Amlodipine Besylate Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Amlodipine Besylate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Amlodipine Besylate Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Amlodipine Besylate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Amlodipine Besylate Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Amlodipine Besylate Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Amlodipine Besylate Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Amlodipine Besylate Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. China Resources Double-Crane Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 80. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. China Resources Double-Crane Pharmaceutical Main Business
Table 82. China Resources Double-Crane Pharmaceutical Latest Developments
Table 83. Pfizer Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 85. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. North China Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 90. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. North China Pharmaceutical Main Business
Table 92. North China Pharmaceutical Latest Developments
Table 93. AstraZeneca Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. AstraZeneca Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 95. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. AstraZeneca Main Business
Table 97. AstraZeneca Latest Developments
Table 98. Sanofi Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 100. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Roche Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 105. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Bristol-Myers Squibb Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 110. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bristol-Myers Squibb Main Business
Table 112. Bristol-Myers Squibb Latest Developments
Table 113. Yangtze River Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 115. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Yangtze River Pharmaceutical Main Business
Table 117. Yangtze River Pharmaceutical Latest Developments
Table 118. Shanghai Shyndec Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 120. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Shanghai Shyndec Pharmaceutical Main Business
Table 122. Shanghai Shyndec Pharmaceutical Latest Developments
Table 123. Jingfeng Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 124. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 125. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Jingfeng Pharmaceutical Main Business
Table 127. Jingfeng Pharmaceutical Latest Developments
Table 1. Amlodipine Besylate Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Amlodipine Besylate Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 5 Milligrams
Table 4. Major Players of 10 Milligrams
Table 5. Global Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 6. Global Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Amlodipine Besylate Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Amlodipine Besylate Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 11. Global Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Amlodipine Besylate Tablets Revenue by Application (2018-2023)
Table 13. Global Amlodipine Besylate Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Amlodipine Besylate Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Amlodipine Besylate Tablets Sales by Company (2018-2023) & (K Units)
Table 16. Global Amlodipine Besylate Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Amlodipine Besylate Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Amlodipine Besylate Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Amlodipine Besylate Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Amlodipine Besylate Tablets Producing Area Distribution and Sales Area
Table 21. Players Amlodipine Besylate Tablets Products Offered
Table 22. Amlodipine Besylate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Amlodipine Besylate Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Amlodipine Besylate Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Amlodipine Besylate Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Amlodipine Besylate Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Amlodipine Besylate Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Amlodipine Besylate Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Amlodipine Besylate Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Amlodipine Besylate Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 34. Americas Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 38. Americas Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 39. APAC Amlodipine Besylate Tablets Sales by Region (2018-2023) & (K Units)
Table 40. APAC Amlodipine Besylate Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Amlodipine Besylate Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Amlodipine Besylate Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 44. APAC Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 45. Europe Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 46. Europe Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 50. Europe Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Amlodipine Besylate Tablets Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Amlodipine Besylate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Amlodipine Besylate Tablets Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Amlodipine Besylate Tablets Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Amlodipine Besylate Tablets
Table 58. Key Market Challenges & Risks of Amlodipine Besylate Tablets
Table 59. Key Industry Trends of Amlodipine Besylate Tablets
Table 60. Amlodipine Besylate Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Amlodipine Besylate Tablets Distributors List
Table 63. Amlodipine Besylate Tablets Customer List
Table 64. Global Amlodipine Besylate Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Amlodipine Besylate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Amlodipine Besylate Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Amlodipine Besylate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Amlodipine Besylate Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Amlodipine Besylate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Amlodipine Besylate Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Amlodipine Besylate Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Amlodipine Besylate Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Amlodipine Besylate Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. China Resources Double-Crane Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 80. China Resources Double-Crane Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. China Resources Double-Crane Pharmaceutical Main Business
Table 82. China Resources Double-Crane Pharmaceutical Latest Developments
Table 83. Pfizer Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 85. Pfizer Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. North China Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. North China Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 90. North China Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. North China Pharmaceutical Main Business
Table 92. North China Pharmaceutical Latest Developments
Table 93. AstraZeneca Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. AstraZeneca Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 95. AstraZeneca Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. AstraZeneca Main Business
Table 97. AstraZeneca Latest Developments
Table 98. Sanofi Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 100. Sanofi Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Roche Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Roche Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 105. Roche Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Roche Main Business
Table 107. Roche Latest Developments
Table 108. Bristol-Myers Squibb Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol-Myers Squibb Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 110. Bristol-Myers Squibb Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bristol-Myers Squibb Main Business
Table 112. Bristol-Myers Squibb Latest Developments
Table 113. Yangtze River Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 115. Yangtze River Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Yangtze River Pharmaceutical Main Business
Table 117. Yangtze River Pharmaceutical Latest Developments
Table 118. Shanghai Shyndec Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 120. Shanghai Shyndec Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Shanghai Shyndec Pharmaceutical Main Business
Table 122. Shanghai Shyndec Pharmaceutical Latest Developments
Table 123. Jingfeng Pharmaceutical Basic Information, Amlodipine Besylate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 124. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Product Portfolios and Specifications
Table 125. Jingfeng Pharmaceutical Amlodipine Besylate Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Jingfeng Pharmaceutical Main Business
Table 127. Jingfeng Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amlodipine Besylate Tablets
Figure 2. Amlodipine Besylate Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amlodipine Besylate Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Amlodipine Besylate Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amlodipine Besylate Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5 Milligrams
Figure 10. Product Picture of 10 Milligrams
Figure 11. Global Amlodipine Besylate Tablets Sales Market Share by Type in 2022
Figure 12. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Amlodipine Besylate Tablets Consumed in Hospital
Figure 14. Global Amlodipine Besylate Tablets Market: Hospital (2018-2023) & (K Units)
Figure 15. Amlodipine Besylate Tablets Consumed in Pharmacy
Figure 16. Global Amlodipine Besylate Tablets Market: Pharmacy (2018-2023) & (K Units)
Figure 17. Global Amlodipine Besylate Tablets Sales Market Share by Application (2022)
Figure 18. Global Amlodipine Besylate Tablets Revenue Market Share by Application in 2022
Figure 19. Amlodipine Besylate Tablets Sales Market by Company in 2022 (K Units)
Figure 20. Global Amlodipine Besylate Tablets Sales Market Share by Company in 2022
Figure 21. Amlodipine Besylate Tablets Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Amlodipine Besylate Tablets Revenue Market Share by Company in 2022
Figure 23. Global Amlodipine Besylate Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Amlodipine Besylate Tablets Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 26. Americas Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 27. APAC Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 28. APAC Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 29. Europe Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 30. Europe Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Americas Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 34. Americas Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 35. Americas Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 36. Americas Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 37. United States Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Amlodipine Besylate Tablets Sales Market Share by Region in 2022
Figure 42. APAC Amlodipine Besylate Tablets Revenue Market Share by Regions in 2022
Figure 43. APAC Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 44. APAC Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 45. China Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 53. Europe Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 54. Europe Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 55. Europe Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 56. Germany Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 65. Egypt Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Amlodipine Besylate Tablets in 2022
Figure 71. Manufacturing Process Analysis of Amlodipine Besylate Tablets
Figure 72. Industry Chain Structure of Amlodipine Besylate Tablets
Figure 73. Channels of Distribution
Figure 74. Global Amlodipine Besylate Tablets Sales Market Forecast by Region (2024-2029)
Figure 75. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Amlodipine Besylate Tablets
Figure 2. Amlodipine Besylate Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amlodipine Besylate Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Amlodipine Besylate Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Amlodipine Besylate Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 5 Milligrams
Figure 10. Product Picture of 10 Milligrams
Figure 11. Global Amlodipine Besylate Tablets Sales Market Share by Type in 2022
Figure 12. Global Amlodipine Besylate Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Amlodipine Besylate Tablets Consumed in Hospital
Figure 14. Global Amlodipine Besylate Tablets Market: Hospital (2018-2023) & (K Units)
Figure 15. Amlodipine Besylate Tablets Consumed in Pharmacy
Figure 16. Global Amlodipine Besylate Tablets Market: Pharmacy (2018-2023) & (K Units)
Figure 17. Global Amlodipine Besylate Tablets Sales Market Share by Application (2022)
Figure 18. Global Amlodipine Besylate Tablets Revenue Market Share by Application in 2022
Figure 19. Amlodipine Besylate Tablets Sales Market by Company in 2022 (K Units)
Figure 20. Global Amlodipine Besylate Tablets Sales Market Share by Company in 2022
Figure 21. Amlodipine Besylate Tablets Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Amlodipine Besylate Tablets Revenue Market Share by Company in 2022
Figure 23. Global Amlodipine Besylate Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Amlodipine Besylate Tablets Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 26. Americas Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 27. APAC Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 28. APAC Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 29. Europe Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 30. Europe Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Amlodipine Besylate Tablets Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Amlodipine Besylate Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Americas Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 34. Americas Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 35. Americas Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 36. Americas Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 37. United States Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Amlodipine Besylate Tablets Sales Market Share by Region in 2022
Figure 42. APAC Amlodipine Besylate Tablets Revenue Market Share by Regions in 2022
Figure 43. APAC Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 44. APAC Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 45. China Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 53. Europe Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 54. Europe Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 55. Europe Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 56. Germany Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Amlodipine Besylate Tablets Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Amlodipine Besylate Tablets Sales Market Share by Application (2018-2023)
Figure 65. Egypt Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Amlodipine Besylate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Amlodipine Besylate Tablets in 2022
Figure 71. Manufacturing Process Analysis of Amlodipine Besylate Tablets
Figure 72. Industry Chain Structure of Amlodipine Besylate Tablets
Figure 73. Channels of Distribution
Figure 74. Global Amlodipine Besylate Tablets Sales Market Forecast by Region (2024-2029)
Figure 75. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Amlodipine Besylate Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Amlodipine Besylate Tablets Revenue Market Share Forecast by Application (2024-2029)
